Market Closed - Nyse 04:00:01 2024-04-18 pm EDT 5-day change 1st Jan Change
200.8 USD +0.28% Intraday chart for STERIS plc -2.65% -8.66%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Steady Pre-Bell Thursday MT
STERIS to Sell Dental Business to Peak Rock Capital for $787.5 Million in Equity Transaction MT
Peak Rock Capital LLC entered into a definitive agreement to acquire Dental segment of STERIS plc for $800 million. CI
Transcript : STERIS plc, Q3 2024 Earnings Call, Feb 08, 2024
Steris beats third-quarter estimates on strong medical procedure demand RE
Steris Fiscal Q3 Earnings, Revenue Increase; Fiscal 2024 Guidance Revised MT
STERIS plc Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
STERIS plc Revises Financial Guidance for the Fiscal Year 2024 CI
MORNING BID AMERICAS-Global calm returns, regional banks rumble RE
Steris Keeps Quarterly Dividend at $0.52 a Share, Payable March 22 to Shareholders of Record Feb. 23 MT
STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024 CI
Morgan Stanley Cuts Price Target on STERIS to $215 From $225, Keeps Equalweight Rating MT
BD forecasts full-year profit below estimates on China headwinds RE
ANALYST RECOMMENDATIONS : Biogen, Conocophillips, Kellanova, Take Two, Tesla... Our Logo
Transcript : STERIS plc, Q2 2024 Earnings Call, Nov 08, 2023
Steris' quarterly revenue beats estimates on strength in Healthcare segment RE
Steris Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Reaffirmed MT
Tranche Update on STERIS plc's Equity Buyback Plan announced on May 3, 2023. CI
STERIS plc Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024 CI
MORNING BID AMERICAS-Some payback, but bonds hug gains on oil RE
STERIS plc Announces Quarterly Interim Dividend, Payable on December 21, 2023 CI
Piper Sandler Adjusts Price Target on STERIS to $215 From $220, Maintains Neutral Rating MT
All hail the resilience of the US economy Our Logo
ANALYST RECOMMENDATIONS : Adobe, Live Nation, Meta, Snap, Wpp... Our Logo
Chart STERIS plc
More charts
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals); - development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide; - manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers. Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%). Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
200.8 USD
Average target price
239.8 USD
Spread / Average Target
+19.43%
Consensus
  1. Stock Market
  2. Equities
  3. STE Stock
  4. News STERIS plc
  5. STERIS : Agrees to Acquire Cantel Medical at $84.7 per Share